arginine vasopressin has been researched along with Adipocere in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, AM; Swaab, DF | 1 |
| Alkemade, A; Bisschop, PH; Borgers, AJ; Fliers, E; Siljee, JE; Swaab, DF; Van Someren, EJ | 1 |
| Erkut, ZA; Pool, C; Swaab, DF | 1 |
| Capodice, CE; Weaver, DR | 1 |
| Lee, S; Rivier, C; Torres, G | 1 |
| Arai, H; Iizuka, R; Noguchi, I | 1 |
| Beal, MF; Bird, ED; Martin, JB; Mazurek, MF | 1 |
1 review(s) available for arginine vasopressin and Adipocere
| Article | Year |
|---|---|
Corticotropin-releasing hormone and arginine vasopressin in depression focus on the human postmortem hypothalamus.
Topics: Alzheimer Disease; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Depressive Disorder; Female; Humans; Hypothalamo-Hypophyseal System; Hypothalamus; Male; Pituitary-Adrenal System; Postmortem Changes; Sex Characteristics; Sex Factors; Stress, Psychological | 2010 |
6 other study(ies) available for arginine vasopressin and Adipocere
| Article | Year |
|---|---|
Arginine vasopressin immunoreactivity is decreased in the hypothalamic suprachiasmatic nucleus of subjects with suprasellar tumors.
Topics: Aged; Aged, 80 and over; Arginine Vasopressin; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Perceptual Disorders; Pituitary Neoplasms; Postmortem Changes; Suprachiasmatic Nucleus; Vasoactive Intestinal Peptide; Visual Fields | 2013 |
Glucocorticoids suppress corticotropin-releasing hormone and vasopressin expression in human hypothalamic neurons.
Topics: Adult; Aged; Arginine Vasopressin; Corticotropin-Releasing Hormone; Feedback; Female; Glucocorticoids; Humans; Hypothalamus; Male; Middle Aged; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Postmortem Changes; Protein Precursors; Supraoptic Nucleus; Vasopressins | 1998 |
Postmortem stability of melatonin receptor binding and clock-relevant mRNAs in mouse suprachiasmatic nucleus.
Topics: Animals; Arginine Vasopressin; Biological Clocks; Cell Cycle Proteins; In Situ Hybridization; Male; Mice; Mice, Inbred C3H; Nuclear Proteins; Period Circadian Proteins; Postmortem Changes; Receptors, Cell Surface; Receptors, Cytoplasmic and Nuclear; Receptors, Melatonin; RNA Stability; RNA, Messenger; Suprachiasmatic Nucleus; Time Factors | 2001 |
Immunocytochemical and in situ hybridization detection of hypothalamic neuropeptides from postmortem unfixed rat brains.
Topics: Adrenalectomy; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Hypothalamus; Immunohistochemistry; In Situ Hybridization; Male; Neuropeptides; Oxytocin; Postmortem Changes; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Fixation | 1992 |
A study on postmortem stability of vasopressin messenger RNA in rat brain compared with those in total RNA and ribosomal RNA.
Topics: Animals; Arginine Vasopressin; Blotting, Northern; Half-Life; Hypothalamus; Male; Postmortem Changes; Rats; Rats, Inbred Strains; RNA, Messenger; RNA, Ribosomal, 18S; RNA, Ribosomal, 28S | 1991 |
Vasopressin in Alzheimer's disease: a study of postmortem brain concentrations.
Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Arginine Vasopressin; Brain Chemistry; Female; Humans; In Vitro Techniques; Male; Middle Aged; Postmortem Changes; Radioimmunoassay | 1986 |